|1||Not yet recruiting||
Maternal and Fetal Compatibility in ART-oocyte Donor Influences Live Birth Rate
Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages
Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NGS for HLA Typing of Donors and récipients oh Hematopoietic Stem Cells
Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
† Study has passed its completion date and status has not been verified in more than two years.